Greene Barry E 4
4 · Sage Therapeutics, Inc. · Filed Aug 7, 2024
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2024-08-05$8.96/sh−12,273$109,966→ 85,067 total - Award
Common Stock
2024-08-05+50,400→ 97,340 total
Footnotes (1)
- [F1]On February 13, 2024, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 126,000 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on August 5, 2024, resulting in the vesting of the PSUs as to 50,400 shares.